IT1175814B - Resine solfoniche ad attivita' terapeutica,loro preparazione e composizioni farmaceutiche che le contengono - Google Patents

Resine solfoniche ad attivita' terapeutica,loro preparazione e composizioni farmaceutiche che le contengono

Info

Publication number
IT1175814B
IT1175814B IT19960/84A IT1996084A IT1175814B IT 1175814 B IT1175814 B IT 1175814B IT 19960/84 A IT19960/84 A IT 19960/84A IT 1996084 A IT1996084 A IT 1996084A IT 1175814 B IT1175814 B IT 1175814B
Authority
IT
Italy
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
active compound
therapeutic activities
Prior art date
Application number
IT19960/84A
Other languages
English (en)
Other versions
IT8419960A0 (it
IT8419960A1 (it
Inventor
Elso Manghisi
Giuseppe Cascio
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of IT8419960A0 publication Critical patent/IT8419960A0/it
Priority to IT19960/84A priority Critical patent/IT1175814B/it
Priority to DE8585102208T priority patent/DE3585963D1/de
Priority to AT85102208T priority patent/ATE75614T1/de
Priority to EP85102208A priority patent/EP0154895B1/en
Priority to ZA851611A priority patent/ZA851611B/xx
Priority to US06/709,081 priority patent/US4587242A/en
Priority to JP60046298A priority patent/JPH0623104B2/ja
Priority to ES541089A priority patent/ES8700932A1/es
Publication of IT8419960A1 publication Critical patent/IT8419960A1/it
Application granted granted Critical
Publication of IT1175814B publication Critical patent/IT1175814B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT19960/84A 1984-03-09 1984-03-09 Resine solfoniche ad attivita' terapeutica,loro preparazione e composizioni farmaceutiche che le contengono IT1175814B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT19960/84A IT1175814B (it) 1984-03-09 1984-03-09 Resine solfoniche ad attivita' terapeutica,loro preparazione e composizioni farmaceutiche che le contengono
DE8585102208T DE3585963D1 (de) 1984-03-09 1985-02-28 Sulfonierte harze mit therapeutischer wirksamkeit, deren darstellung sowie diese enthaltende arzneimittel.
AT85102208T ATE75614T1 (de) 1984-03-09 1985-02-28 Sulfonierte harze mit therapeutischer wirksamkeit, deren darstellung sowie diese enthaltende arzneimittel.
EP85102208A EP0154895B1 (en) 1984-03-09 1985-02-28 New sulfonic resins having a therapeutical activity, preparation thereof and pharmaceutical compositions containing them
ZA851611A ZA851611B (en) 1984-03-09 1985-03-04 New sulfonic resins having a therapeutical acitivity,preparation thereof and pharmaceutical compositions containing them
US06/709,081 US4587242A (en) 1984-03-09 1985-03-07 Sulfonic resins having a therapeutical activity, preparation thereof and pharmaceutical compositions containing them
JP60046298A JPH0623104B2 (ja) 1984-03-09 1985-03-08 治療作用をもつ新規な、スルホン樹脂を含有する医薬及びその製造方法
ES541089A ES8700932A1 (es) 1984-03-09 1985-03-08 Procedimiento para preparar una nueva composicion farmaceutica administrable por via oral que contiene una derivado de benzotiazepina.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19960/84A IT1175814B (it) 1984-03-09 1984-03-09 Resine solfoniche ad attivita' terapeutica,loro preparazione e composizioni farmaceutiche che le contengono

Publications (3)

Publication Number Publication Date
IT8419960A0 IT8419960A0 (it) 1984-03-09
IT8419960A1 IT8419960A1 (it) 1985-09-09
IT1175814B true IT1175814B (it) 1987-07-15

Family

ID=11162658

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19960/84A IT1175814B (it) 1984-03-09 1984-03-09 Resine solfoniche ad attivita' terapeutica,loro preparazione e composizioni farmaceutiche che le contengono

Country Status (8)

Country Link
US (1) US4587242A (it)
EP (1) EP0154895B1 (it)
JP (1) JPH0623104B2 (it)
AT (1) ATE75614T1 (it)
DE (1) DE3585963D1 (it)
ES (1) ES8700932A1 (it)
IT (1) IT1175814B (it)
ZA (1) ZA851611B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364620A (en) * 1983-12-22 1994-11-15 Elan Corporation, Plc Controlled absorption diltiazem formulation for once daily administration
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
FR2623714B1 (fr) * 1987-11-26 1990-04-20 Ethypharm Sa Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu
US5008433A (en) * 1988-05-18 1991-04-16 Marion Laboratories, Inc. 2-hydroxy-3-(4-methoxyphenyl)-3-(2-aminophenylthio)propionic acid, 8'-phenylmenthyl ester, especially for diltiazem
DK0702009T3 (da) * 1994-09-16 1999-02-01 Orion Corp Fermion Fremgangsmåde til fremstilling af farmaceutisk aktive benzothiazepinderivater
WO2007001300A1 (en) * 2005-06-28 2007-01-04 Ucb, S.A. Multiple active drug-resin conjugate
US20050142097A1 (en) * 2003-12-29 2005-06-30 Deepak Thassu Multiple active drug resin conjugate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857194A (en) * 1957-07-05 1960-12-29 Clinical Products Ltd Therapeutic agents comprising ion-exchange resins
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
BR6915295D0 (pt) * 1969-01-25 1973-04-12 Tanabe Seiyaku Co Indicador cronologico de evento em transmissao televisada
US4364928A (en) * 1979-10-23 1982-12-21 Roussel-Uclaf Novel salts of ion exchange resins of the acid type
US4369175A (en) * 1981-07-27 1983-01-18 Ciba-Geigy Corporation Process for the manufacture of prolonged action vincamine preparations, the vincamine preparations so obtained, and medicaments containing them

Also Published As

Publication number Publication date
JPS60208918A (ja) 1985-10-21
EP0154895B1 (en) 1992-05-06
IT8419960A0 (it) 1984-03-09
JPH0623104B2 (ja) 1994-03-30
ATE75614T1 (de) 1992-05-15
ES8700932A1 (es) 1986-11-16
IT8419960A1 (it) 1985-09-09
DE3585963D1 (de) 1992-06-11
EP0154895A3 (en) 1987-05-06
US4587242A (en) 1986-05-06
ES541089A0 (es) 1986-11-16
ZA851611B (en) 1985-11-27
EP0154895A2 (en) 1985-09-18

Similar Documents

Publication Publication Date Title
MY102038A (en) 4-substituted androstendione derivatives and process for their preparation
BR9808069A (pt) Novos compostos, seus usos e preparações
EP0154895A3 (en) New sulfonic resins having a therapeutical activity, preparation thereof and pharmaceutical compositions containing them
ES540758A0 (es) Un procedimiento para la preparacion de una composicion blanqueante de poroxido de hidrogeno.
ATE147625T1 (de) Hydantoin- oder imidazolidintrionderivate zur vorbeugung oder behandlung von niereninsuffizienz
MX9603606A (es) N-metil-n-[(1s)-1-fenil-2-((3s)-3-hidroxipirrolidin-1-il) etil]-2,2-difenil-acetamida.
IT9022340A0 (it) Processo per la preparazione del (+)-cis-3-(acetossi)-5-(2-(dimetilammino)etil)-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin-4-(5h)-one cloridrato.
US4806530A (en) Pharmaceutical compositions based on diltiazem and lysine acetylsalicylate
PH24727A (en) Agents having renal function improving effect
SE8403042L (sv) Hypolipidemisk komposition
GB2190290B (en) Use of benzothiazepine derivatives in pharmaceutical compositions for improving constitution of lipids in blood.
HUT70033A (en) Process for producing synergetic pharmaceutical composition containing calcium channel blocking agent and calcium compound or vitamin d
JPS6419A (en) Renal function-improving and diuretic agent
JPS56156218A (en) Inhibitor against blood platelet agglutination
IT8420148A0 (it) Procedimento per la preparazione del(+)-cis-5-[2-(dimetilamino)etil]-2,3-diidro-3-idrossi-2-(p-metossifenil)-1,5-benzotiazepin-4(5h)-one acetato cloridrato
IT1230931B (it) Derivati di 2 ammino 1,2,3,4 tetraidronaftalene ad attivita' cardiovascolare, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT8422701A0 (it) Procedimento per il recupero delcis(+)-3-acetilossi-5-[2-(dimetilammino)etil]-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin-4-(5h)-one cloridrato
NO157701C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 15,16-methylen-17alfa-pregna-4,6-dien-21-carboxylsyresalter.
IT8419671A0 (it) Derivati del 3-(acetilossi)-5-[2(dimetilamino)etil]-2,3-diidro-2(4-metossifenil)-1,5-benzotiazepin-4(5h)-one, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
PT83307A (en) Spirobenzofuran-2 (3h),1'-cycloheptanes a process and interme diates for their preparation and their use as medicaments
IT8521855A0 (it) Procedimento per il recupero delcis(+)-3-acetilossi-5-[2-(dimetilammino)etil]-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin-4-(5h)-one cloridrato
DK732088A (da) Fremgangsmaade til fremstilling af 1,5-benzothiazepinderivater
KR920011495A (ko) 치료용 활성을 갖는 설폰산수지, 그것의 제제 및 그것을 함유한 약제 조성물
ES2020722A6 (es) Procedimiento para la purificacion de intermedios para la preparacion de benzotiacepinas.
IT9019002A1 (it) Composti otticamente attivi per la profilassi dell'insufficienza coronarica acuta e cronica, loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 452

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 452, 19930701; ISTITUTO LUSOFARMACO D ITALIA S.P.A .

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970326